Preferences among five nicotine treatments based on information versus sampling.

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a controlled clinical trial.

Smokers' minimal exposure to nicotine replacement treatments (NRTs) may account for poor compliance and outcome with these treatments.

This study tested effects of information versus sampling of NRTs on smokers' preferences and expectations.

Who Took Part

By PubMed's age tags, the people studied were adults, middle-aged adults and older adults, both men and women.

Subjects were given computer-based presentations on NRTs (INF) and rated and ranked use variables (e.g., ease, sensory/ritual, perceived relief, embarrassment) and overall choice for "use to quit." After INF testing, subjects sampled each NRT (SMP) and again rated and ranked drugs.

How the Study Was Run

The researchers set it up as a crossover study.

In the crossover set-up each of the participants took both Therapeutic nicotine (patch, non-peptide) and the comparison in turn, acting as their own control.

What Was Measured

Smokers' minimal exposure to nicotine replacement treatments (NRTs) may account for poor compliance and outcome with these treatments.

This study tested effects of information versus sampling of NRTs on smokers' preferences and expectations.

Topics PubMed links to this paper include Chewing Gum, Drug Administration Routes, Nebulizers and Vaporizers, Nicotine, Patient Education as Topic, Patient Satisfaction and Self Administration.

What This Means in Plain Language

The paper is a crossover study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2008 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.